
Ambu will increase options on the ear, nose and throat (ENT) endoscopy market with a new product feature for its single-use endoscope, the medtech company has announced in a press release.
By adding a new feature, Ambu’s single-use scope and its accompanying monitor, dubbed Ascope 4 Rhinolaryngo Slim and Aview 2 Advance HD monitor, will support the imaging procedure known as Fiberoptic Endoscopic Evaluation of Swallowing (FEES), meaning that Ambu will address an additional one million procedures within the ENT segment every year, according to the announcement.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app